Brief: Cyclerion Announces Transformational Relaunch As A Neuropsychiatric Company
23/09/2025 23:30
Sept 23 (Reuters) - Cyclerion Therapeutics Inc CYCN.O: CYCLERION ANNOUNCES TRANSFORMATIONAL RELAUNCH AS A NEUROPSYCHIATRIC COMPANY CYCLERION THERAPEUTICS INC - PHASE 2 TRIAL FOR CYCLERION'S LEAD PROGRAM EXPECTED IN 2026 Source text: ID:nGNXccsRg2 Further company coverage: CYCN.O ((Reuters.Briefs@thomsonreuters.com;))